EFRAIN ARROYO PENA: Open Payments
NPI 1982745063 · MAYAGUEZ, PR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 7 payments from 6 companies in 2025. Trend: 2023 $107 · 2024 $115 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $51 |
| ABBVIE INC. | 1 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| Amgen Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: MAVYRET, SYMTUZA, REPATHA, DELSTRIGO, Biktarvy, JARDIANCE.
Industry payments across PR — which companies pay providers there.
